Advertisement

Topics

Cormedix, Inc.: CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update

16:21 EST 9 Nov 2017 | FinanzNachrichten

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time; Recent Corporate and Clinical Highlights: - Executed $5 Million Combined Securities Purchase and Backstop Agreement; - Continued to Ad...

Original Article: Cormedix, Inc.: CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update

NEXT ARTICLE

More From BioPortfolio on "Cormedix, Inc.: CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...